Table 1 Characteristics of monthly treatments in the Papua New Guinea clinical trial
| Â | Intervention arm | Control arm | Drug formulations per tablet | |||
|---|---|---|---|---|---|---|
Time points | IPTp | Tablets | IPTp | Tablets | SP | DP |
Day 0 | SP + DP | 6 | SP + Placebo | 6 | 500 mg/25 mg | 40 mg/320 mg |
Day 1 | DP | 3 | Placebo | 3 | – | 40 mg/320 mg |
Day 2 | DP | 3 | Placebo | 3 | – | 40 mg/320 mg |